- 专利标题： Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
-
申请号： US18634326申请日： 2024-04-12
-
公开(公告)号： US20240350608A1公开(公告)日： 2024-10-24
- 发明人: Bishwa Raj Bhetuwal , Kaushik Dutta , Jianxin Gu , Sunayana Kapil , Jin-Hwan Kim , Justin Keith Moran , Suddham Singh , YuYing Yang
- 申请人： Pfizer Inc.
- 申请人地址： US NY New York
- 专利权人： Pfizer Inc.
- 当前专利权人： Pfizer Inc.
- 当前专利权人地址： US NY New York
- 主分类号： A61K39/09
- IPC分类号： A61K39/09 ; A61K39/00 ; A61K39/385 ; A61K47/64
摘要：
The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates), kits comprising said immunogenic compositions and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions.
信息查询
